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Sequences which encode Epstein-Barr virus (EBV) RNA in nasopharyngeal
carcinoma (NPC) tissue have been identified. We utilized human biopsy material
directly as well as NPC grown in nude mice. Total RNA was extracted from the
tumor material and separated into polyadenylated and nonpolyadenylated frac-
tions by oligodeoxythymidylate-cellulose chromatography. This material was
used as template to construct 32P-labeled cDNA. The labeled cDNAs were
hybridized to Southern blots of recombinant EBV DNA fragments. Three of the
biopsies, F, 49, and 55, contained polyadenylated RNA homologous to the EBV
BamHI fragments V and K, and EcoRI-DIJhet. These same fragments encode the
most abundant polyribosomal RNAs in latently infected lymphoblastoid cell lines.
The sequences which encoded nonpolyadenylated RNA in NPC tumor 49 were
more extensive and included BamHI fragments C, V, B, E, and K, and EcoRI
fragments DIJhet, E, F, and G1, a result that indicates selective polyadenylation
in EBV RNA processing. A fourth biopsy, NPC tumor 18, contained polyadenyl-
ated RNA homologous to the BamHI fragments H, B, K, Y, Bi, I1, and A and
EcoRI fragments F and G2. A similar pattern of transcription was identified in
three tumor specimens from nude mice, 4, 5, and 8. Transformation of lympho-
cytes did not oc,..ur after cocultivation in vitro with explants from these nude mice
tumors. This transcriptional pattern may represent an activated state of the EBV
genome, formerly not detected in tumor tissue, which is analogous to the state of
abortive infection identified in induced in vitro cell systems.
The Epstein-Barr virus (EBV) is the etiologi-
cal agent of infectious mononucleosis, a benign
lymphoproliferative disease (16), and is associat-
ed with African Burkitt's lymphoma, a monoclo-
nal B lymphoblastoid malignancy (10), and naso-
pharyngeal carcinoma (NCP), a tumor arising
from the squamous epithelium of the nasophar-
ynx (19). Although EBV is thought to be lym-
photrophic, in NPC tissue EBV DNA is detect-
ed in the malignant epithelial cells and not within
the lymphocytes which heavily infiltrate the
carcinomatous tissue (38). Biochemical analyses
of the role of EBV in NPC have been hampered
because the malignant epithelial cells cannot be
cultivated in vitro, and pathological tissue can
only be obtained by biopsy. However, these
tumors can be grown in nude mice, which elimi-
nates the infiltrating human lymphoid elements.
These epithelial tumors when cultivated in the
nude mice retain EBV DNA and the EBV nucle-
ar antigen (25, 33).
t Present address: National Taiwan University, Taipei, Tai-
wan.
Each of the pathological processes associated
with EBV has a distinct pattern of antibody
response to viral antigens (17). Patients with
NPC have elevated immunoglobulin G (IgG) and
IgA titers (15, 17) to the viral capsid antigen (14)
and early antigen (EA) (18) and to an EBV-
associated DNase (2). These titers increase with
tumor burden and can be used as indicators for
prognosis (19). In addition, rises in EA titers
precede the onset of NPC by 1 to 2 years (8).
Although EA and viral capsid antigen cannot be
detected in latently infected, growth-trans-
formed lymphocytes and are only detected in
cells which are abortively or productively infect-
ed, the serological profiles of patients with NPC
and Burkitt's lymphoma suggest that an activated
state of viral expression, perhaps analogous to
an abortive infection, may be an important part
of the malignant process. Moreover, in NPC,
expression of EA and viral capsid antigen most
likely occurs in tissues which stimulate IgA
production.
Analyses of EBV transcription have been
conducted in latently, abortively, and produc-
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tively infected lymphoblastoid cell lines. In la-
tently infected lymphocytes, three relatively
abundant polyadenylated RNAs encoded by
BamHI V, X, and H, BamHI-K, and EcoRI-
Dhet are transcribed (23, 35). Several lines of
evidence indicate that the transcript from
BamHI-K encodes a component of EBV nuclear
antigen (20, 32).
EBV transcription in abortive infection has
been studied in latently infected Raji cells which
can be induced to a more permissive infection
with halogenated nucleosides, sodium butyrate,
or phorbol esters (24). EA can be detected in
these cells. After induction, transcription from
BamHI fragment H greatly increases, and addi-
tional sequences encode polyadenylated RNA,
including BamHI fragments A, B, E, and M.
In permissively infected cells, the complexity
of polyadenylated RNA is approximately that of
the single-stranded EBV genome. More than 50
EBV RNAs have been identified in B95-8 cells
(21) and in HR-1 cells (37), which have been
induced to a high level of permissive infection by
treatment with the tumor promoter 12-0-tetra-
decanoyl-phorbol-13-acetate. Some of these
RNAs are classified as persistent early RNAs
based on their continued synthesis in the pres-
ence of phosphonoacetic acid (21). These RNAs
have been shown to encode components of EA
in in vitro translations (22). Many of these
persistent early RNAs are encoded by the addi-
tional sequences that are transcribed in Raji cells
after induction. From these various in vitro
observations, it appears that abortive infection
may be characterized by the synthesis of a
subset of early viral replicative functions.
Based on such in vitro data, it should then be
possible to ascertain the state of viral expression
at the level of RNA by determining sequence
complexity and transcriptional patterns directly
in NPC-an important step forward toward un-
derstanding the virus-cell relations and the dif-
ferent antibody responses in the EBV-associat-
ed diseases. In the course of this work, we
uncovered an EBV transcriptional pattern in
NPC tissues, which we term "activated," that
up to now had only been seen in vitro with the
experimental manipulations mentioned earlier.
We also analyzed EBV transcription in NPC
cultivated in nude mice.
MATERIALS AND METHODS
Tumor material. NPC tissue documented histopath-
ologically by G. Pearson and colleagues, Mayo Clinic,
Rochester, Minn., and A. Huang and colleagues, Duke
University, Durham, N.C., was used for this work.
Specimens, NPC F, C, 49, and 55 were designated as
World Health Organization (WHO) NPC class WHO
3, and specimen 18 was WHO class 1. The NPC
specimens passaged in nude mice were all WHO class
3.
Isolation of RNA. All glassware used in the isolation
and selection of RNA was treated with 0.2% diethyl
pyrocarbonate for 2 h and then autoclaved or baked
overnight at 250°C. The tumor samples were homoge-
nized in a Tissumizer (Tekmar Inc., Cincinnati, Ohio)
in a solution consisting of 4 M guanidine thiocyanate
(Tridom, Inc., Hauppage, N.Y.), 0.5% Sarkosyl, 0.1 M
2-mercaptoethanol, 0.1% antifoam A (Sigma Chemical
Co., St. Louis, Mo.), and 25 mM sodium citrate, pH
7.0 (3). The RNA was purified through a cesium
chloride step gradient (30).
Polyadenylated and nonpolyadenylated RNAs were
separated by oligodeoxythymidylate-cellulose chro-
matography (1) (type 3; Collaborative Research, Wal-
tham, Mass.).
Identification of viral DNA which encodes RNA in
nasopharyngeal tumor tissue. To identify the EBV
sequences which are transcribed in the tumor tissue,
cDNA to polyadenylated and nonpolyadenylated
RNA was synthesized with avian myeloblastosis virus
reverse transcriptase (J. Beard, Life Sciences, St.
Petersburg, Fla.). The reaction mixture contained: 2 to
30 jig of RNA; 200 ,Ci of [32P]dCTP (New England
Nuclear Corp., Boston, Mass.); 500 liM dATP, dGTP,
and dTTP (P-L Biochemicals, Milwaukee, Wis.); 30 mM
2-mercaptoethanol; 10 mM MgClI; 0.01% Nonidet P-40;
6 ,ug of actinomycin D per ml; and 30 U of reverse
transcriptase in a 100-,u reaction volume. The reaction
was primed with 0.1 absorbance units at 260 nm of
oligodeoxythymidine (P-L Biochemicals) to provide a
further selection for polyadenylated RNA. Regions of
the EBV genome which may be transcribed but not
polyadenylated were identified by synthesis of cDNA,
primed with 200 p.g of random oligodeoxynucleotides
per ml (33), to the RNA obtained from the effluent of the
oligodeoxythymidine-cellulose column.
The 32P-labeled cDNAs were then hybridized to
Southern blots (31) of recombinant DNA EcoRI frag-
ments of EBV W91 DNA (27). In addition, blots of
recombinant DNA of the BamHl fragments V, K, R,
B1, 11, Wi, C, and H (4) were included in the hybridiza-
tions to verify possible hybridization to regions of
particular interest. The BamHI fragments V, K, and H
are transcribed in latently infected lymphocyte cell lines
(24). BamHI-C encodes two polyadenylated RNAs of
very low abundance and two nonpolyadenylated RNAs
(35). The fragments Bi, 11, and Wl contain the se-
quences deleted from the B95 strain (26, 27) and are
thought to encode, in part, the most abundant RNAs in
Burkitt tumor tissue (6).
Preparation of Southern blots and hybridization con-
ditions. The recombinant DNAs of the three largest
EcoRI fragments, A, B, and C, were digested with
EcoRI and BamHI, the recombinant DNAs of the
EcoRI fragments DlJhet, E, F, Gl, G2, and H were
digested with EcoRl, and the recombinant DNAs of the
BamHI fragments were digested with BamHI. The
fragments were separated by electrophoresis through a
0.5% agarose gel and transferred to nitrocellulose (31).
The blots ofeach fragment were cut into duplicate strips.
One strip of each set was hybridized to EBV HR1 virion
DNA labeled with [32P]dCTP by nick translation (29).
This step determined the position of the EBV frag-
ment(s) on the blot and provided a comparison of the
relative strength of each blot.
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The nitrocellulose blots of the EBV fragments were
pretreated for 4 h at 72°C in hybridization buffer consist-
ing of 1Ox Denhardt reagent (7), 100 pg of single-
stranded calf-thymus DNA per ml, 100 ,ug of polyadeny-
late (Sigma) per ml, 0.2% sodium dodecyl sulfate and
6x SSC (lx SSC is 0.15 M NaCl pus 0.015 M sodium
citrate). The labeled cDNA was hybridized to the
pretreated blots in fresh hybridization buffer at 72°C
for 18 h. The blots were washed at 72°C in 0.2%
sodium dodecyl sulfate in SSC in decreasing concen-
trations to 0.1x SSC.
RESULTS
Identification of the EBV fragments tran-
scribed in NPC obtained by biopsy. (i) NPC
specimens F and C. Biopsies F and C were each
less than 0.05 g. Therefore, the 32P-labeled
cDNA was synthesized from the total RNA
prepared from these biopsies and primed with
oligodeoxythymidine as the only selection for
polyadenylated sequences. The hybridizations
with cDNA to RNA from specimen F, cDNA to
RNA from specimen C, and 3'P-labeled HR1
DNA to the blots of the recombinant EBV DNA
fragments are shown in Fig. 1. The hybridization
with EBV HR1 DNA to each fragment is posi-
tioned on the left and is aligned with the cDNA
hybridization. The strongest hybridization with
the cDNAs prepared from specimens F and C
was to the BamHI V fragment, which is generat-
ed by a single cut within the large internal
repeated sequence of the EBV genome. This
hybridization was detected both on the blot of
the EcoRIIBamHI digestion of the EcoRI-A
fragment and on the blot of the BamHI V
fragment. Hybridization to undigested BamHI-
V recombinant DNA was present on the blot of
this fragment. Hybridization was also detected
to the BamHI fragments X and C, which are
adjacent to BamHI-V, each of which contains a
part of the internal repeated sequence. The
cDNA to RNA from specimen NPC F also
hybridized to BamHI-K within EcoRI-B and
weakly to the clone of the fused-termini EcoRI
fragment DIJhet. The regions of EBV that were
transcribed in these two tumors are represented
in the EBV genome map in Fig. 7a.
(ii) NPC specimens 55 and 49. Hybridization
with cDNA to the polyadenylated RNA from
NPC specimens 55 and 49 was detected to the
BamHI fragments V and K and EcoRI-DIJhet
(Fig. 2a and b). The intensity of hybridization to
the EcoRI DIJhet fragment was much stronger
in these specimens compared to the hybridiza-
tions with the cDNAs prepared from NPC speci-
mens F and C, which might reflect differences in
the relative abundance of transcription from this
fragment.
The oligodeoxynucleotide-primed cDNA to
the nonpolyadenylated RNA from biopsy 49
hybridized to the BamHI fragments C, H, and V
within EcoRI-A; to BamHI fragments B, E, and
K within EcoRI-B; and to EcoRI fragments D,
E, F, and Gl (Fig. 2c). These results indicate
that there was good selection for polyadenylated
sequences in the previous hybridization and that
a subset of the total EBV RNAs which are
transcribed in NPC 49 is polyadenylated. Similar
results with RNA from EBV-infected lympho-
blastoid cell cultures suggests selective process-
ing of EBV viral RNA (23, 24).
(iii) NPC specimen 18. Hybridization with
cDNA to the polyadenylated RNA from speci-
men 18 was detected to BamHI-H within EcoRI-
A; to BamHI fragments B and K and faintly to
fragments E and Y within EcoRI-B; to BamHI
fragments Bi, I1, Vl, and A within EcoRI-C; to
EcoRI-DIJhet; and weakly to EcoRI fragments
F and G2 (Fig. 3a). The BamHI fragments H and
B1 contain homologous duplicated sequences (5,
27). Therefore, cDNA from RNA transcribed
from either of the duplicated sequences will
hybridize to B1 and H. Hybridization with the
cDNA to the nonpolyadenylated RNA was de-
tected to BamHI fragments C, H, B1, and V and
to EcoRI fragments DIJhet, F, and E (Fig. 3b).
In summary, although sequences from BamHI-V
can be detected in the nonpolyadenylated RNA,
no hybridization was detected to BamHI-V with
the cDNA from the polyadenylated RNA from
NPC 18. Moreover, hybridization was readily
detected to the BamHI-H fragment from which
transcription greatly increases in iododeoxyuri-
dine (IUdR)-induced Raji cells (24) and which
encodes an abundant 2.5-kilobase persistent ear-
ly RNA in a productive infection (21). Hybrid-
ization was also detected to additional se-
quences, many of which were transcribed after
induction of Raji cells with IUdR.
Identification of the EBV sequences transcribed
in NPC grown in nude mice. NPC, like other
tissues of epithelial origin, can be cultivated only
with difficulty, if at all, in vitro. Therefore, we
turned to specimens of NPC that had been
cultivated in nude mice. The three original NPC
specimens were from three Taiwanese patients.
Five tumors derived by cultivation of these three
specimens in nude mice were analyzed. Three of
the tumors are different passages of the same
original NPC. One of the tumors is a lympho-
blastoid tumor which resulted from the inocula-
tion of a lymphoblastoid cell line established
during attempts to cultivate NPC tissue, but it is
not epithelial tissue.
(i) NM 4, 5, and 8. Nude mouse tumors (NMs)
4, 5, and 8 are different passages of the same
original NPC specimen. NM 4 had been pas-
saged in nude mice 38 times, NM 5 had been
passaged 39 times, and NM 8 had been passaged
13 times, cultivated in vitro once, and then
passaged an additional 20 times. Cocultivation
J. VIROL.
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FIG. 1. Identification of the EBV sequences which encode polyadenylated RNA in NPC biopsy specimens
F and C. 32P-labeled cDNAs synthesized to the polyadenylated RNA from tumor F (panel A) and to the
polyadenylated RNA from tumor C (panel B) were hybridized to duplicate strips of blots of restriction enzyme
fragments of EBV. The EcoRl fragments, A, B, and C were digested with EcoRl and BamHI. The BamHI
fragments within each of the EcoRI fragments are indicated at the left. A duplicate strip of each blot, which was
hybridized to 32P-labeled HR1 viral DNA, is shown to the left of the cDNA hybridization. The arrows indicate
hybridization with the cDNA probe.
of in vitro explants of these tumors with lympho-
cytes did not result in lymphocyte transforma-
tion.
The, transcriptional patterns of these tumor
passage levels were very similar. The cDNAs
prepared from the polyadenylated RNA from
NMs 4, 5, and 8 (Fig. 4a, b, and c) hybridized to
BamHI-H within EcoRI-A; to BamHI fragments
B, K, and Y within EcoRI-B; to BamHI-B1
within EcoRI-C; and to EcoRI fragments D, E,
F, G2, and H. The cDNA from NMs 4 and 5 also
hybridized to BamHl fragments I1, Vl, and A
within EcoRI-C. The bacterial clones containing
the EcoRI fragments E, GI, G2, and H also
contain EcoRI-C to which hybridization can be
detected with the cDNA from NMs 4 and 5. The
arrows denote the positions of E, G1, G2, and
H.
The cDNA from the nonpolyadenylated RNA
from NM 8 hybridized to BamHI fragments F,
H, and V within EcoRI-A; to BamHI fragments
B, E, and K within EcoRI-B; to BamHI frag-
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FIG. 2. EBV transcription in NPC biopsy specimens 55 and 49. The hybridization with 32P-labeled cDNAs to
polyadenylated RNA from NPC 55 (A) and polyadenylated (B) and nonpolyadenylated (C) RNA from NPC 49
are shown in the right-hand strip of each fragment and are indicated with arrows. The left strip was hybridized to
32P-labeled HR1 viral DNA.
ments Bi, I1, and A within EcoRI-C; and to
EcoRI fragments D, E, and F (Fig. 4d). These
results indicate that RNA processing through
selective adenylation is retained in the NPC
tissue grown in nude mice.
(ii) NM 1. NM 1 was passaged in nude mice 38
times. Unlike the other NMs transformation of
lymphocytes occurred after cocultivation with
cells from this tumor, which indicates the pres-
ence of infectious virus. The cDNA to the
polyadenylated RNA hydridized to all of the
BamHI fragments within EcoRI-B; to BamHI
fragments BE. I1, Vl, W, and A within EcoRI-C;
and to EcoRI fragments D, E, F, G1, G2, and H
(Fig. 5). Within EcoRI-A, abundant transcrip-










































FIG. 3. EBV sequences which encode RNA in NPC 18. Hybridization with cdNAs to the polyadenylated
RNA (A) and nonpolyadenylated RNA (B) to restriction enzyme fragments of EBV are shown in the right strip of
each blot. The arrows indicate hybridization with the cDNA probe. Hybridization with 32P-labeled HR1 viral
DNA is presented on the left. The BamHI-B1 clone contains a subpopulation of deleted fragments to which
hybridization is also detected. The EcoRI-G2 clone also contains EcoRl-C, to which hybridization can be
detected. The arrow denotes the position of G2.
ed. The pattern of relative abundance indicated
by these hybridization results is similar to that
found in a productively infected cell line. This is
the only sample from which we have detected
strong hybridization to BamHI-F, which en-
codes 11 RNAs in a productive infection (21).
(iii) NM 3. NM 3 is the 31st passage in nude
mice of a lymphoblastoid tumor which resulted
from the inoculation of a lymphoblastoid cell
line established from NPC tissue. The cDNA to
the polyadenylated RNA from this tumor hy-
bridized very strongly to BamHI-H in addition
to BamHI fragments C, V, E, K, and Bi and
EcoRI-Dhet (Fig. 6). Hybridization with the
cDNA to the nonpolyadenylated RNA detected
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FIG. 4. Identification of the EBV sequences which encode RNA in an NPC tumor grown in nude mice. NMs
4, 5, and 8 are different passages of the same NPC tumor. 32P-labeled cDNAs to the polyadenylated RNAs from
NM 4 (A), NM 5 (B), and NM 8 (C) and to the nonpolyadenylated RNA from NM 8 (D) were hybridized to
duplicate blots of the EBV restriction enzyme fragments. The clones of EcoRl fragments E, Gi, G2, and H also
contain EcoRI-C to which hybridization can be detected. The arrows denote the positions of E, Gl, G2, and H.
EcoRI-A; all of the BamHI fragments within
EcoRI-B; EcoRI fragments D and G2; and
BamHI-B1.
DISCUSSION
We identified three patterns of transcription in
NPC tissue that are analogous to the latent,
abortive, and productive infections identified in
latently infected and itiduced lymphoblastoid
cell cultures. To present and contrast the NPC
transcriptional patterns best, we grouped them
according to pattern and compared them with
the corresponding pattern in the EBV lympho-
blastoid cell lines. In Fig. 7a, the transcriptional
patterns in NPC tissues F, C, 49, and 55 and in
the lymphoblastoid tumor grown in nude mice,
NM 3, are compared with that of a latently
infected cell line (23). The patterns of expression
in these tissues are quite similar. Whether the
apparent differences in the relative abundance of
transcription from particular fragments in the
NPC material represent fluctuations in tran-
scription or reflect differences in preservation of
template RNA is at this point unknown.
NPC 18 (Fig. 7b) is of particular interest
because the regions of EBV which encode RNA
in this tumor are different from the other NPC
specimens or the latently infected cell lines. The
transcriptional pattern is similar yet distinct
from that of IUdR-induced Raji cells (24). One
difference is the readily detectable transcription
from BamHI-Y, a region of the genome that
does not encode RNA in latent or IUdR-induced
Raji cells but does generate five RNAs, two of
which are early, in a productive infection (21).
The other obvious difference is the lack of
polyadenylated RNA from BamHI-V. Tran-
scription from this fragment is present in Raji
cells and is characteristic of latent infection.
However, this transcription persists after induc-
tion of Raji cells with IUdR. This may be the
result of incomplete induction, and the resultant
transcriptional pattern may be a composite of
the RNAs expressed in latently infected and
induced cells. One perspective of the transcrip-
tional pattern in NPC 18 is that it represents a
state of abortive infection not simulated by any
of the in vitro systems. This finding also sug-
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FIG. 5. Identification of the EBV sequences which encode RNA in an NPC grown in nude mice which
produces infectious virus.
latent infection to an intermediate state of acti-
vated transcription. Such transitions, in some
way tied to the course of the disease, may
explain the different levels of EBV antibody
response detected in patients with NPC.
As it is known that NPC tumor tissue grown in
nude mice can produce virus (11, 34), the EBV
transcription in these tumors may represent an
artificial derepression of the genome. The effect
of this derepression is quite different in the
epithelial tumors, NMs 4, 5, 8, and 1, compared
with the lymphoblastoid tumor NM 3. The lym-
phoblastoid tumor retains a restricted pattern of
expression, with the most abundant transcrip-
tion encoded by BamHI fragments V and H and
EcoRI-D. The strong hybridization to BamHI-H
probably reflects some activation and may be
due to the abundant 2.5-kilobase early replica-
tive RNA encoded by this fragment in a produc-
tive infection (21). In contrast, the epithelial
tumors grown in nude mice do not contain
polyadenylated RNA from BamHI-V and con-
tain transcripts from other additional regions of
the EBV genome. The similarity of the tran-
scriptional patterns for NMs 4, 5, and 8 to that of
NPC 18 is striking, with the most abundant
transcription encoded by BamHI fragments H,
B, K, Y, B1, I1, and A. Moreover, comparison
of the transcriptional patterns for NMs 4, 5, and
8, or NPC 18 with that in NM 1, which is
apparently producing virus, reveals several dif-
ferences between a productive infection and the
state of activation in NMs 4, 5, and 8. The
sequence complexity of RNA is greatest in NM
1 and includes, in addition to all the sequences
transcribed in NMs 4, 5, and 8, abundant tran-
scription from BamHI-F and all of the sequences
within EcoRI-B.
The activated state of EBV in the NMs and in
NPC 18 is not entirely surprising in that whenev-
er EBV has been introduced into nonlymphoid
host cells, either by microinjection (12), trans-
fection (13), or receptor implantation (36), the
early antigen has been expressed but not EBV
nuclear antigen. It is clear from the data present-
ed here that latent, abortive, and productive
infections can occur in epithelial cells. Howev-
er, essential for the maintenance of latency in
epithelial cells may be the presence of EBV-
reactive T lymphocytes. Therefore, the loss of
the infiltrating lymphocytes during the growth of
the tumor tissue in nude mice might promote an
activated state of viral expression.
NPCs are classified into three histopathologi-
cal subtypes by the WHO, which differ in the
extent of differentiation of the malignant epithe-
lial cell and the degree of lymphocyte infiltra-
tion. The undifferentiated carcinomas, class
WHO 3, which are heavily infiltrated with lym-
phocytes, are clearly associated with EBV,
since most patients have elevated EBV antibody
titers. The association of EBV with the most
differentiated NPC, class WHO 1, is not as
consistent, since patients usually do not have
I I
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FIG. 6. Transcription in a lymphoblastoid tumor grown in nude
polyadenylated RNA (A) or nonpolyadenylated RNA (B) are identified.
elevated EBV titers. NPC 18 is a keratinizing
squamous cell carcinoma, class WHO 1. Per-
haps the lack of lymphocyte infiltration or the
differentiated state of the cell influences EBV
expression in such tumors. One paradox of this
situation is that although many of the sequences
transcribed in NPC 18 are thought to encode
components of EA (22), this patient did not have
an elevated titer to EA or viral capsid antigen. It
is possible that the EBV expression within the
tumor had recently changed and that the patient
did not yet have a detectable immune response
or that EBV expression is blocked at some step
mice. The sequences which encode
past adenylation. Alternatively, the class of
RNAs expressed in this tumor may represent
functions expressed before the appearance of
the early antigen. A class of proteins has been
identified in a permissive EBV system that is
transiently expressed early after infection (9).
These proteins are not precipitated with antisera
to the early antigen. If the RNAs transcribed in
NPC 18 encode these proteins, the state of viral
expression would be intermediate between la-
tent and replicative and would not necessarily
imply cell death.
It is apparent from these data that the same
J. VIROL.
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FIG. 7. Summary of EBV transcription in NPC. (A) Latent patterns of expression. Comparison of NPCs F,
C, 49, and 55 and NM 3 to a latently EBV-infected lymphocyte line (23). (B) Activated patterns of expression.
Comparison of the NPC 18 and NMs 4, 5, 8, and 1, to an induced EBV-infected lymphocyte line (24).
sequences which are transcribed in growth-
transformed, latently infected lymphoblastoid
cell lines are also transcribed in NPC tissue.
However, it is also clear that other sequences
can be transcribed and that at times the state of
infection may be more analogous to an abortive
infection. Based on the similar transcriptional
patterns of the four tumors in this activated
state, NPC 18 and NMs 4, 5, and 8, it is possible
that particular functions are consistently ex-
pressed in such abortive infections in NPC tis-
sue.
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